Novartis

Last updated June 2021

Public Use
1
1
1
1
1
1
1
Novartis Commitment to Diversity in Clinical Trials
Diversity in clinical trials is integral to who we are at Novartis. Our purpose is to reimagine
medicine to improve and extend the lives of all people – inclusive of race, ethnicity, gender,
age, sexual orientation, disability, location and socioeconomic status.

Underrepresentation and lack of diversity in clinical trials, of both patients and investigators, is
a key issue that...